• 1. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330
• 2. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622
• 3. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 4. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 5. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095

Comprehensive Guide to (2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride (CAS No. 1207447-38-8)

(2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride (CAS No. 1207447-38-8) is a specialized chiral amino acid derivative with significant potential in pharmaceutical research and organic synthesis. This compound, featuring a tetrahydropyran (oxan-4-yl) group attached to the amino acid backbone, is increasingly studied for its unique structural properties and applications in drug discovery. Researchers and industry professionals are actively exploring its role in peptide modification, enzyme inhibition, and as a building block for bioactive molecules.

The molecular structure of (2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride includes a protonated amino group and a carboxylic acid functionality, making it highly versatile for chemical transformations. Its hydrochloride salt form enhances solubility in aqueous systems, which is crucial for biological assays and formulation development. Recent studies highlight its potential in addressing challenges related to drug delivery systems and targeted therapies, aligning with current trends in personalized medicine.

One of the most compelling aspects of 1207447-38-8 is its application in the design of peptidomimetics—molecules that mimic peptides but exhibit improved stability and bioavailability. This is particularly relevant given the growing interest in next-generation therapeutics that overcome the limitations of traditional peptide drugs. The oxan-4-yl moiety introduces conformational constraints that can enhance binding affinity to biological targets, a feature highly sought after in GPCR-targeted drug discovery.

From a synthetic chemistry perspective, (2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride serves as a valuable intermediate for asymmetric synthesis. Its chiral center allows for the construction of enantiomerically pure compounds, which is critical in developing pharmaceuticals with reduced side effects. The compound’s stability under various reaction conditions makes it suitable for multistep synthetic routes, including solid-phase peptide synthesis (SPPS) and click chemistry applications.

Market trends indicate rising demand for custom amino acid derivatives like 1207447-38-8, driven by advancements in bioconjugation techniques and proteomics research. Suppliers and contract research organizations (CROs) are expanding their portfolios to include such niche compounds, catering to the needs of academic labs and biotech firms. Additionally, the compound’s relevance in antibody-drug conjugate (ADC) development positions it as a key player in the booming targeted cancer therapy sector.

For researchers working on central nervous system (CNS) disorders, (2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride offers intriguing possibilities. Its ability to modulate neurotransmitter analogs could pave the way for novel treatments for conditions like neurodegenerative diseases and chronic pain. This aligns with the increasing focus on blood-brain barrier (BBB)-penetrant molecules in modern pharmacology.

Quality control and characterization of CAS 1207447-38-8 are paramount for ensuring reproducibility in research. Techniques such as HPLC purity analysis, mass spectrometry, and chiral chromatography are routinely employed to verify the compound’s identity and enantiomeric excess. These analytical protocols are essential for meeting the stringent requirements of Good Laboratory Practice (GLP) and regulatory submissions.

In summary, (2R)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride (CAS No. 1207447-38-8) represents a multifaceted tool for medicinal chemists and life science researchers. Its structural uniqueness, combined with broad applicability in drug design and biochemical studies, makes it a compound of enduring interest. As the scientific community continues to explore structure-activity relationships (SAR) and new therapeutic modalities, this amino acid derivative is poised to remain at the forefront of innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)